SHANNON BORDEN: Open Payments
NPI 1366152951 · HOUSTONS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 40 payments from 15 companies in 2025. Trend: 2023 $909 · 2024 $496 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $175 |
| UCB, Inc. | 7 | $169 |
| GENZYME CORPORATION | 3 | $87 |
| PFIZER INC. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| SpringWorks Therapeutics, Inc. | 2 | $44 |
| ACADIA Pharmaceuticals Inc | 2 | $39 |
| Boston Scientific Corporation | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: REPATHA, Briviact, Fintepla, NURTEC ODT, LEQVIO, GOMEKLI, FABRAZYME, NUPLAZID.
Industry payments across TX — which companies pay providers there.
